Pharma & Biotech - Page 11

Independent pharmacies have long served as a frontline point of health care access for millions of Americans, but mounting financial pressures are testing their ability to remain open. Michelle Britt, senior vice

Roche is investing $750 million to double the size of its existing production facility at the Genentech campus in Hillsboro, Oregon, on the western outskirts of Portland. The Swiss pharmaceutical giant’s latest

Aurinia Pharmaceuticals (AUPH) has reached a patent infringement settlement with Teva Pharmaceuticals (TEVA) over its flagship lupus drug Lupkynis (voclosporin). The deal should prevent Teva from launching a generic version of voclosporin

Customer satisfaction across the pharmacy sector is splitting sharply, with mail-order services rising while traditional retail pharmacies struggle to retain consumer confidence. The findings come from the J.D. Power 2026 U.S. Pharmacy

Ultragenyx Pharmaceutical (RARE) has earned its first FDA approval in gene therapy, landing an accelerated green light for its treatment targeting glycogen storage disease type Ia. The FDA approved pariglasgene brecaparvovec-opnr, previously

Boehringer Ingelheim has strengthened its position among the most respected companies in rare disease, building on significant gains recorded in the previous year’s survey. The German drugmaker climbed another four places in

CDMO SK Pharmteco has completed two advanced manufacturing facilities at its production campus in Swords, Ireland, significantly expanding its pharmaceutical ingredient capabilities. The company first announced plans for a phased expansion at

SK Biopharmaceuticals has struck its first-ever settlement with a generic drug manufacturer seeking to produce a copycat version of its epilepsy treatment Xcopri (cenobamate). The agreement is with India’s MSN Laboratories, which

Regeneron Pharmaceuticals (REGN) has secured a landmark FDA approval for its monoclonal antibody garetosmab, now commercially known as Pasatru, after more than ten years in development. The drug becomes the second FDA-cleared